Form 8-K - Current report:
SEC Accession No. 0001104659-25-035121
Filing Date
2025-04-15
Accepted
2025-04-15 16:06:29
Documents
30
Period of Report
2025-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2512159d1_8k.htm   iXBRL 8-K 230471
2 EXHIBIT 3.1 tm2512159d1_ex3-1.htm EX-3.1 10174
3 EXHIBIT 3.2 tm2512159d1_ex3-2.htm EX-3.2 7084
4 EXHIBIT 3.3 tm2512159d1_ex3-3.htm EX-3.3 6690
5 EXHIBIT 10.1 tm2512159d1_ex10-1.htm EX-10.1 48834
6 EXHIBIT 10.2 tm2512159d1_ex10-2.htm EX-10.2 172216
7 EXHIBIT 10.10 tm2512159d1_ex10-10.htm EX-10.10 17731
8 EXHIBIT 10.14 tm2512159d1_ex10-14.htm EX-10.14 192001
9 EXHIBIT 10.15 tm2512159d1_ex10-15.htm EX-10.15 110778
10 EXHIBIT 10.16 tm2512159d1_ex10-16.htm EX-10.16 38405
11 EXHIBIT 10.17 tm2512159d1_ex10-17.htm EX-10.17 109193
12 EXHIBIT 14.1 tm2512159d1_ex14-1.htm EX-14.1 90568
13 EXHIBIT 23.1 tm2512159d1_ex23-1.htm EX-23.1 1928
14 EXHIBIT 99.1 tm2512159d1_ex99-1.htm EX-99.1 15959
15 EXHIBIT 99.2 tm2512159d1_ex99-2.htm EX-99.2 10073
20 GRAPHIC tm2512159d1_8kimg001.jpg GRAPHIC 23233
21 GRAPHIC tm2512159d1_ex99-1img001.jpg GRAPHIC 3088
  Complete submission text file 0001104659-25-035121.txt   1581117

Data Files

Seq Description Document Type Size
16 XBRL TAXONOMY EXTENSION SCHEMA tvrd-20250415.xsd EX-101.SCH 3289
17 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tvrd-20250415_def.xml EX-101.DEF 26653
18 XBRL TAXONOMY EXTENSION LABEL LINKBASE tvrd-20250415_lab.xml EX-101.LAB 36627
19 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tvrd-20250415_pre.xml EX-101.PRE 25308
32 EXTRACTED XBRL INSTANCE DOCUMENT tm2512159d1_8k_htm.xml XML 5207
Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478
Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654
Tvardi Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 25839542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)